This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Albert Einstein College of Medicine, Harvard College, Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis. Active years: 2016-2019.
Location History:
- De Belt, NL (2016)
- Amsterdam, NL (2019)
Company Filing History:
1 out of 513 
1 out of 3,071 
1 out of 16 
Years Active: 2016-2019
Title: Matthijs Raaben: Innovator in Genetic Research
Introduction
Matthijs Raaben is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of genetic research, holding 2 patents that focus on identifying genetic elements and developing methods for treating infections.
Latest Patents
Raaben's latest patents include innovative methods for identifying genetic elements that affect phenotypes. The first patent describes a process that utilizes non-living cells subjected to mutagenesis treatment. These cells are sorted based on phenotype and analyzed to identify previously unknown genetic elements related to health conditions, external stress, or drug responses, particularly in cancer. The second patent outlines methods and assays for treating filovirus infections. This invention involves using agents that inhibit specific proteins, making them potential candidates for treating and preventing such infections.
Career Highlights
Throughout his career, Matthijs Raaben has worked with prestigious institutions, including the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital and Albert Einstein College of Medicine. His work has significantly advanced the understanding of genetic factors in health and disease.
Collaborations
Raaben has collaborated with notable colleagues such as Thijn Reinout Brummelkamp and Joppe Daniël Maria Nieuwenhuis. These collaborations have further enriched his research and contributions to the scientific community.
Conclusion
Matthijs Raaben's innovative work in genetic research and his patents demonstrate his commitment to advancing medical science. His contributions have the potential to impact health outcomes significantly.